Hormone Therapy 2016 Revised Global Consensus Statement

“The Revised Global Consensus Statement on
Menopausal Hormone Therapy is aimed at
updating and expanding the areas of consensus”.1

Umbrella
What may the Hormone Therapy 2016 Revised Global Consensus Statement Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Hormone Replacement Therapy (HRT)
  • Hormone Therapy (HT)
  • Menopausal Hormone Therapy (MHT)
  • Revised Global Consensus Statement on Menopausal Hormone Therapy

Revised Global Consensus Statement

What is the Revised Global Consensus Statement on Menopausal Hormone Therapy?

In the Revised Global Consensus Statement on Menopausal Hormone Therapy (Revised Global Consensus Statement) – endorsed by seven menopause-related organizations – published online 20 June 2016, the authors explain:

“The publication of the Global Consensus on Menopausal Hormone Therapy in 2013 by leading global menopause societies succeeded in presenting guidelines in a troubled therapeutic area that are helpful to both health-care providers and potential users of menopausal hormone therapy (MHT). The revised statement is aimed at updating and expanding the areas of consensus”.2

Organizations

Which organizations endorse the Revised Global Consensus Statement?

Organizations which endorse the Revised Global Consensus Statement (in alphabetical order) are the:

Organizations

  1. Asia Pacific Menopause Federation
  2. Endocrine Society
  3. European Menopause and Andropause Society
  4. Federation of Latin American Menopause Societies
  5. International Menopause Society
  6. International Osteoporosis Foundation
  7. North American Menopause Society

Informed Decision

What are the Revised Global Consensus Statement authors hopeful of?

The Revised Global Consensus Statement authors note:

“Hopefully, this statement will enable health-care providers to offer those women in midlife, who may benefit from MHT, the opportunity to make an informed decision”.3

Acknowledgement

What do the Revised Global Consensus Statement authors acknowledge?

The Revised Global Consensus Statement authors acknowledge:

“The revised statement contains only areas of consensus and does not replace the more detailed and fully referenced recommendations of the individual societies (referenced at the end of the document)”.4

Consensus

What are some points of consensus in the Revised Global Consensus Statement?

Some points of consensus are:

Hormone Therapy 2016 Revised Global Consensus Statement

  • “MHT, including tibolone and the combination of conjugated equine estrogens and bazedoxifene (CE/BZA), is the most effective treatment for vasomotor symptoms (VMS) associated with menopause at any age, but benefits are more likely to outweigh risks if initiated for symptomatic women before the age of 60 years or within 10 years after menopause
  • If MHT is contraindicated or not desired for treatment of VMS, selective serotonin reuptake inhibitors and serotoninnorepinephrine reuptake inhibitors such as paroxetine, escitalopram, venlafaxine and desvenlafaxine, which have been shown to be effective in randomized controlled trials (RCTs), may be considered. Gabapentin may also be considered
  • Local low-dose estrogen therapy is preferred for women whose symptoms are limited to vaginal dryness or associated discomfort with intercourse or for the prevention of recurrent urinary tract infections”.5

Vasomotor Symptoms

What are vasomotor symptoms?

DotS the definition of vasomotor symptoms may vary. The North American Menopause Society’s definition is:

“Vasomotor symptoms. Also known as hot flashes and night sweats, common symptoms during perimenopause and early postmenopause”.6

Health Care Provider

What if I choose to use MHT?

If you choose to use MHT, it may be in your best interest to also choose to talk to your health care provider about this.

One of the points of consensus in the Revised Global Consensus Statement is:

  • “The option of MHT is an individual decision in terms of quality of life and health priorities as well as personal risk factors such as age, time since menopause and the risk of VTE, stroke, ischemic heart disease and breast cancer. MHT should not be recommended without a clear indication for its use”.7

What is VTE?

MHT can be an abbreviation for Venous Thromboembolism.

Health Topics A-Z

Where may I find Health Topics A-Z related to Hormone Therapy 2016 Revised Global Consensus Statement?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Hormone Therapy 2016 Revised Global Consensus Statement?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

New or Updated

  1. 2016 IMS Recommendations on Women’s Midlife Health and Menopause Hormone Therapy
  2. Askearlymenopause.org [Ask EM] [+ Video: What Is Early Menopause?]
  3. BMS & WHC’s 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  4. BMS TV: Bioidentical Hormones
  5. BMS TV: HRT and Breast Cancer: Overall Risks and Benefits
  6. BMS TV: HRT and the Risk of Breast Cancer
  7. BMS TV: Hormone Replacement Therapy (HRT)
  8. BMS TV: Urogenital Atrophy
  9. Bioidentical Custom Compounded Hormone Therapy
  10. Bioidentical Hormone Therapy
  11. Bioidentical Hormones: Are They Safer?
  12. Compounded Bioidentical Hormone Therapy [Video]
  13. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  14. Deciding About Hormone Therapy
  15. Deciding About Hormone Therapy Use
  16. Dr Louise Newson: The Truth About the Menopause & HRT
  17. Find A Menopause Practitioner [United States and Other]
  18. Find An AMS Doctor [Australasian Menopause Society i.e. Australia and New Zealand]
  19. Find Your Nearest BMS Menopause Specialist [British Menopause Society]
  20. Global Consensus Statement on Menopausal Hormone Therapy
  21. Guidance on Menopausal Hormone Therapy
  22. HRT & Menopause Extra
  23. HRT – Types, Doses and Regimens
  24. HRT: Benefits and Risks
  25. HRT: The History
  26. Hormone Replacement Therapy
  27. Hormone Replacement Therapy (HRT)
  28. Hormone Replacement Therapy (HRT): Benefits and Risks of Hormone Replacement Therapy (HRT)
  29. Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
  30. Hormone Therapy: Is It Right for You?
  31. Hot Flashes
  32. Hot Flashes: What Can I Do? [+ Video: What Are the Signs and Symptoms of Menopause?]
  33. I Forgot To Ask the Doctor – E9: The Menopause: Can Every Woman That Wants It Have HRT?
  34. Joint Position Statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
  35. Later Years (Around 50 Years and Over): Menopause and Post Menopause Health – Hormone Replacement Therapy (HRT) [+ Video: Is HRT Bad for You?]
  36. Menopausal Hormone Therapy
  37. Menopausal Hormone Therapy Trends Before Versus After 2002: Impact of the Women’s Health Initiative Study Results
  38. Menopausal Hormone Therapy and Breast Cancer Risk
  39. Menopausal Hormone Therapy and Venous Thromboembolism
  40. Menopausal Hormone Therapy, Heart Disease and Stroke
  41. Menopause
  42. Menopause
  43. Menopause
  44. Menopause
  45. Menopause & Hormones: Questions To Ask Your Doctor
  46. Menopause Hormone Therapy: Who Shouldn’t Take It?
  47. Menopause Management Options
  48. Menopause Map: Downloadable Resources – My Personal Path Print Tools: Menopause Medication Tracker
  49. Menopause Map: Downloadable Resources – My Personal Path Print Tools: Questions for Your Health Care Provider
    Hormone Therapy 2016 Revised Global Consensus Statement
  50. Menopause Patient Information [Videos] 3. The Risks & Benefits of HRT
  51. Menopause Patient Information [Videos] 4. The Different Types of HRT
  52. Menopause Preparedness Toolkit Video Series: Treating Vasomotor Symptoms of Menopause
  53. Menopause Symptoms and Relief
  54. Menopause, Perimenopause, Hormone Therapy and Other Treatments With Madelyn Butler, MD [Podcast]
  55. Menopause Symptoms: Mayo Clinic Expert Outlines Hormone and Nonhormonal Therapies
  56. Menopause Treatment
  57. Menopause Treatment
  58. Menopause Treatments: What Works, What Doesn’t
  59. Menopause and HRT
  60. Menopause: Diagnosis and Management – Information for the Public: Questions To Ask About Menopause [NICE Guideline]
  61. Menopause: Understanding the Changes and Finding Relief | Dr Susan Davis | The Proof Podcast EP 256
  62. Navigating Menopause: Expert Insights and Solutions | Dr Susan Davis | The Proof Podcast EP 245
  63. Nonhormone Treatments for Hot Flashes and Night Sweats
  64. Revised Global Consensus Statement on Menopausal Hormone Therapy
  65. Risks and Benefits of MHT
  66. The 2023 Practitioner’s Toolkit for Managing Menopause
  67. The North American Menopause Society Releases Its 2022 Hormone Therapy Position Statement
  68. Therapy for the Effects of Menopause
  69. Tips To Help Manage Menopause Symptoms
  70. Types of Hormone Therapy
  71. Using HRT (Hormone Replacement Therapy)
  72. Vaginal Dryness
  73. Vaginal Dryness
  74. Vaginal Oestrogen
  75. Video Series-2022: Hormone Therapy: Understanding the Risks and Benefits
  76. Video Series-2022: Perimenopause, Signs, Symptoms, and Solutions
  77. Video Series-2023: Lifestyle Modification and Prevention of Breast Cancer
  78. Video Series-2023: NAMS 2023 Nonhormone Therapies Position Statement for Bothersome Menopause Symptoms
  79. Video Series-2023: New FDA-Approved Nonhormone Option for the Treatment of Hot Flashes
  80. Video: Leslie Cho, MD, Discusses CV Risks, Benefits of Menopausal Hormone Therapy
  81. Videos and Podcasts: Videos – Interviews: A Simple Approach To Menopause: The Menopause Quick Six (www.MQ6.ca)
  82. Videos and Podcasts: Videos – Interviews: Heart Disease, Risk Factors of Developing Heart Disease, and Can I Take Hormones?
  83. Webinars: Previous – Approach To Bone Health In the Perimenopause and Postmenopause?
  84. Webinars: Previous – Brain Teasers: Challenges In the Cranium
  85. Webinars: Previous – Breast Cancer
  86. Webinars: Previous – Clinical Climacteric Conundrums
  87. Webinars: Previous – Primary Prevention of Cardiovascular Disease With MHT – Where Are We Now?
  88. Webinars: Previous – The Early Menopausal Patient
  89. What Everyone Should Know About Menopause Symptoms
  90. Why Didn’t Anyone Tell Me This? Episode 3: Dr Annice Mukherjee: Your Essential Menopause Toolkit

Sources

Where may I find the Sources quoted?

You may find the Sources quoted at:

Sources

  1. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 22 January 2024
  2. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 22 January 2024
  3. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 22 January 2024
  4. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 22 January 2024
  5. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section A: Benefit/Risk Profile of MHT. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 22 January 2024
  6. Menopause Glossary: V – Vasomotor Symptoms. North American Menopause Society http://www.menopause.org/for-women/menopause-glossary#V Accessed: 22 January 2024
  7. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT. Climacteric, 2016;19:4:314 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 22 January 2024
Topic Last Updated: 22 January 2024 – Topic Last Reviewed: 22 January 2024

Print Friendly, PDF & Email
/by